We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protective Antibodies for Malaria Identified by New Blood Test

By Labmedica staff writers
Posted on 13 Mar 2008
The malaria pathogen Plasmodium falciparum carries poisonous sugar molecules called glycosylosphatidylinositols (GPIs) on its surface that can be individually identified. More...
These sugar molecules are the dominant malarial toxins responsible for several pathologic processes associated with severe malaria. A person's immune system can form antibodies against these sugar molecules on the malaria pathogen, which protect against serious illness.

Blood samples taken from adults living in areas of Africa where malaria is endemic contain specific antibodies against particular GPIs. While infection is still possible despite the antibodies, the consequences are less serious. The immune system recognizes the poisonous sugar molecules as foreign bodies and blocks their toxic impact. Not living in high-risk areas, Europeans lack these antibodies. As soon as Europeans are infected with malaria, the number of antibodies increases significantly. Subsequently, there is a direct link between the amount of antibodies and protection against the disease.

A new blood test enables these antibodies to be detected. The method uses 64 pads comprising pinpoint dots affixed to glass slides. Every pad consists of several tiny heaps of different GPIs in varying concentrations. When blood serum is administered to such a pad, antibodies specifically bind to certain sugar molecules. Dyes then reveal to which GPIs the antibodies have become attached.

A chip developed in the laboratory of Prof. Peter Seeberger by a team of ETH Zurich and Swiss Tropical Institute (Zurich, Switzerland) scientists can use minute quantities of blood serum and sugar molecules to determine whether someone has formed particular antibodies against various GPIs. Large amounts of very pure GPIs can be produced synthetically in a laboratory, as the team demonstrated previously.

Using the information obtained from the chip, scientists can produce the specific sugar molecules that the immune system has to recognize. The findings should contribute to developing a sugar-based malaria vaccine and would be particularly beneficial to children in malaria-infested regions.

A report of the team's work was published online in the journal Nature Chemical Biology on March 2, 2008.


Related Links:
Swiss Tropical Institute

New
Gold Member
Hematology Analyzer
Medonic M32B
Collection and Transport System
PurSafe Plus®
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.